Genentech and Biogen Idec, Inc. (Massachusetts) Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!Copenhagen, Denmark; May 17, 2013 Genmab A/S (OMX: GEN) announced today that Genentech and Biogen Idec have…

---

Biogen-Idec | Pharma Commons 2013-05-17 07:00:00

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!BOSTON--(BUSINESS WIRE)--Today the Biogen Idec Foundation announced a $250,000 grant to East End House to dev…

---

Biogen-Idec | Pharma Commons 2013-05-16 07:00:00

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!BOSTON--(BUSINESS WIRE)--Today the Biogen Idec Foundation announced a $250,000 grant to East End House to dev…

---

FDA to review Biogen’s hemophilia A treatment eloctate

The FDA has accepted Biogen Idec's biologics license application for hemophilia A drug candidate eloctate.  -More- …

---